相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical Development of New Antibody-Drug Conjugates in Breast Cancer: To Infinity and Beyond
Romualdo Barroso-Sousa et al.
BIODRUGS (2021)
Unlocking the potential of antibody-drug conjugates for cancer therapy
Joshua Z. Drago et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Emerging strategies for treating metastasis
Mark Esposito et al.
NATURE CANCER (2021)
HER2-Low Breast Cancer: Pathological and Clinical Landscape
Paolo Tarantino et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Jin Sun Lee et al.
CANCERS (2020)
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Antonio Marra et al.
NPJ BREAST CANCER (2020)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
Andre Hennigs et al.
BMC CANCER (2016)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)